No but he should get the blame if there are serious adverse events from drugs released to the general population with shortened trials. Or if drugs that are not efficacious are released. It’s quite possible US FDA approval may not be considered valid internationally if the trial process Is shortened significantly.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
0.025(1.97%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.31 | $1.27 | $258.9K | 200.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3158 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 27132 | 2 |
View Market Depth
| Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |